Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes （CAR-T） for CEA Positive Advanced Malignant Solid Tumors

Conditions: Gastric Cancer; Colon Cancer; Rectal Cancer; Breast Cancer; Lung Cancer; Esophagus Cancer; Cholangiocarcinoma; Pancreas Cancer Interventions: Biological: CEA-targeted CAR-T cells; Biological: CEA-targeted CAR-T cells Sponsors: Chongqing Precision Biotech Co., Ltd; First Affiliated Hospital of Wannan Medical College Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials